United Therapeutics Slips To Q4 Loss - Quick Facts

(RTTNews) - Drug manufacturer United Therapeutics Corp. (UTHR) reported a fourth-quarter net loss of $30.31 million or $0.60 per share, compared to net income of $83.26 million or $1.60 per share in the prior-year quarter.

Excluding item, adjusted net income for the quarter was $160.20 million or $2.88 per share, compared to $84.58 million or $1.62 per share in the year-ago quarter.

On average, twelve analysts polled by Thomson Reuters expected the company to report earnings of $1.51 per share for the quarter. Analysts' estimates typically exclude one-time items.

Total revenues for the quarter increased to $289.30 million from $243.82 million in the same quarter last year. Analysts expected the company to generate revenues of $295.43 million for the quarter.

Total operating expenses nearly tripled to $317.51 million from $115.21 million a year ago.